ArticleBlood advances2023

Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19.

Lukas J Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.